Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
PODD Transcript
Insulet Corporation (PODD) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Neutral6-3
Insulet Corporation (PODD) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral5-13
Insulet Corporation (PODD) Q1 2026 Earnings Call Transcript
Positive5-6
The earnings call indicates strong financial performance with a 20% revenue increase, improved gross margins, and higher net income. The positive outlook for Omnipod revenue growth and operating margin expansion further supports a favorable sentiment. However, the lack of discussion on strategic initiatives and operational updates, along with acknowledgment of risks in forward-looking statements, tempers the overall sentiment to 'Positive'. The absence of market cap information suggests a moderate stock reaction.
Insulet Corporation (PODD) Q4 2025 Earnings Call Transcript
Positive2-18
The earnings call highlights robust financial performance, with revenue and EPS growth exceeding guidance. Positive factors include increased guidance, strong market expansion, and strategic product developments. The Q&A reveals confidence in sustaining growth, a strong competitive moat, and successful integration with Dexcom. Despite some vague management responses, the overall sentiment is highly positive, suggesting a strong positive stock price reaction.
PODD Slides
Insulet Q1 2026 slides: 34% revenue growth amid stock decline2026-05-06
Insulet Q4 2025 slides: revenue soars 31%, stock jumps on strong 2026 outlook2026-02-18
Insulet Q3 2025 slides: revenue surges 30%, guidance raised amid international expansion2025-11-06
Insulet Q2 2025 slides: revenue tops $649M as diabetes tech leader expands globally2025-08-07
PODD Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
